Wed 4/1/2020 12:53 ET
DJIA20978.86897.904.28%TELCO155.763.772.42%GOLD1596.900.320.02%Shanghai2734.5215.590.57%
S&P 5002470.03109.424.43%BANKS283.9019.676.93%OIL20.120.361.79%BITCOIN6218.61207.083.33%
NASDAQ7395.85292.143.95%PHARM534.8115.192.84%US/EU1.090.000.01%Futures2461.12108.544.41%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Happiness Biotech Group - HAPP)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add HAPP
  
From: SunTzu772 (Rep: 1312)Date: 02/27/2020 02:09
Forum: Wall Street Pit - Msg #2818491 - List HAPP msgs Thread #674125852 (Rec: 1)
Select Effective Disinfectants for Use Against the Novel Virus COVID-19

Richard Lowe, Ph.D., MPH
February 26, 2020
Environmental Services

With cases of COVID-19 now confirmed in the United States, the question inevitably being asked by industry professionals is “What disinfectants can I use against this virus?”

Fortunately, regulatory and public health agencies in the US provide clear guidance on what products may be used in outbreaks of emerging pathogens.

In the US, the US Environmental Protection Agency provides emerging viral pathogen guidance on the criteria disinfectants need to meet to be considered effective against an emerging pathogen.

The efficacy criteria are based on the ease with which the three types of viruses—enveloped, large non-enveloped and small non-enveloped viruses—are inactivated by disinfectants. The general idea of the EPA’s policy is that in order for a disinfectant to be considered effective against an emerging pathogen, it must demonstrate efficacy – that is, have an EPA-approved claim – against viruses that are harder to kill than the emerging pathogen.


SARS-CoV-2, the virus responsible for the COVID-19 outbreak, is an enveloped virus and therefore the easiest to kill of the three types of viruses. This means the efficacy criteria for a disinfectant is as follows:

· A disinfectant must be EPA-approved as a hospital/healthcare or broad spectrum disinfectant

· The disinfectant must carry an EPA-approved claim for at least one small or one large non-enveloped virus

· Lastly, the EPA-approved master label must contain emerging pathogen “terms of registration” language describing what emerging pathogen claims the manufacturer can make. Typically, this takes the form of language such as:

Emerging Viral Pathogen Claims

Allowable and subject to the terms described in Agency guidance dated August 19, 2016, “Guidance to Registrants: Process for Making Claims Against Emerging Viral Pathogens not on EPA-Registered Disinfectant Labels

This product qualifies for emerging pathogen claims against:

• Enveloped viruses

• Large non-enveloped viruses

• Small non-enveloped viruses

If the disinfectant satisfies all three criteria, the manufacturer can communicate this information via technical literature distributed exclusively to healthcare facilities, physicians, nurses and public health officials, "1-800" consumer information services, social media sites and company websites, using specific permitted language. The required language must be written in one of the following formats:

[Product name] has demonstrated effectiveness against viruses similar to [name of emerging virus] on hard, [porous and/or non-porous surfaces]. Therefore, [product name] can be used against [name of emerging virus] when used in accordance with the directions for use against [name of supporting virus(es)] on [hard, porous/non-porous surfaces]. Refer to the [CDC or OIE] website at [pathogen-specific website address] for additional information.

[Name of illness/outbreak] is caused by [name of emerging virus]. [Product name] kills similar viruses and therefore can be used against [name of emerging virus] when used in accordance with the directions for use against [name of supporting virus(es)] on [hard, porous/non-porous surfaces]. Refer to the [CDC or OIE] website at [website address] for additional information.

For example, for the current COVID-19 outbreak, a statement using the first example of permitted language for a disinfectant with a claim against Rhinovirus (a small, non-enveloped virus) would read:

Disinfectant X has demonstrated effectiveness against viruses similar to SARS-CoV-2 (formerly 2019-nCoV) on hard, non-porous surfaces. Therefore, Disinfectant X can be used against SARS-CoV-2 (formerly 2019-nCoV) when used in accordance with the directions for use against Rhinovirus on hard, non-porous surfaces. Refer to the CDC or OIE website at https://www.cdc.gov/coronavirus/index.html for additional information.

So now that you know the requirements, what steps can you take to find an effective disinfectant? It’s always best to contact the manufacturer or check its website for disinfectants the manufacturer has determined to have EPA-approved emerging viral pathogens claims. Many manufacturers have issued guidance including lists of eligible products. While looking at manufacturer websites, it is important to look at the specific language used. Claims should not read as “kills SARS-CoV-2” or “effective against SARS-CoV-2,” as this new pathogen is not yet available for EPA testing. Given the new name of SARS-CoV-2 was confirmed on February 12, 2020, some manufacturers may still be using the previous name for the virus, 2019-nCoV.

With the SARS-CoV-2 outbreak continuing, and with COVID-19 cases in the U.S. increasing, albeit slowly, it’s critical that the right information on disinfection selection is provided to healthcare, cleaning and janitorial industry professionals. By following trusted guidance from national regulatory and public health agencies, facilities can help ensure they are best prepared for this as well as any future outbreaks of viral pathogens.

https://www.infectioncontroltoday.com/environmental-services/select-effective-disinfectants-use-against-novel-virus-covid-19

-----

Disinfectant Companies Rising to New High Amid Virus Outbreak
Waiting on Feb sales data .83 eps

https://www.manufacturing.net/economics/news/21118164/disinfectant-companies-rising-to-new-high-amid-virus-outbreak

COVID-19 (Coronavirus) survives on surfaces up to 9 days..this should click soon perhaps after February data # release.

https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html

-----
ANPING, China, Feb. 25, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has officially entered into disinfectants industry. The first batch of 2 million bottles of 75% Alcohol Disinfectant were sold out on launch day. The shipment has begun this week.

The Company has obtained the Sanitation License of Disinfection Product Manufacturer ("Sanitation License") issued by Fujian Provincial Heath Commission, which gives the Company permissions to produce all types of disinfectants, including 75% Alcohol Disinfectant, 84 Disinfectant, and Hand Free Disinfectant, etc. Sanitation License imposes very high standards for the applicants, including the review of the production process, the quality assurance system, the test reports of the production environment and production water, etc. The application process usually takes at least a few months. Due to the outbreak of the Novel Coronavirus, the government has accelerated the application process and gave the Company the approval within 2 weeks.

"We are honored to shoulder the responsibilities to alleviate the supply shortage of epidemic prevention supplies such as disinfectants. Although we are a GMP certified company, we have upgraded and transformed our workshop and production procedures during the application process to meet all the requirements to be a qualified disinfectants manufacturer. We will do our best to produce as much as possible disinfectants products and nutritional products during the epidemic period, and contribute to the prevention and control of the Novel Coronavirus." said Mr. Xuezhu Wang, CEO of the Company.

https://www.prnewswire.com/news-releases/happiness-biotech-officially-entered-into-disinfectants-industry-301010439.html

-----

Sales of Cordyceps Mycelia Products Surged over 100% in January

NANPING, China, Jan. 28, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the sales of its Cordyceps mycelia products surged over 100% in January due to the outbreak of the Wuhan Coronavirus.

As of January 27, 2020, revenue from Cordyceps mycelia products has reached over RMB 8 million (approximately USD 1.2 million), 100% higher than December 2019 and 125% higher than November 2019.

Starting from the end of December 2019, China has seen massive outbreaks of the new coronavirus. The demand for products that targeting people with weak immune system has been stronger than ever. The Company obtained the approval for Cordyceps Mycelia Oral Liquid from the China Food and Drug Administration ("CFDA") back in 1997, being among one of the first companies to receive this approval. According to the results of clinical evaluation, Cordyceps Mycelia Oral Liquid regulates humoral and cellular immunity and improves phagocytosis of macrophages, thus improving body resistance and preventing disease. Such clinical evaluation results were approved by CFDA to be included in Cordyceps Mycelia Oral Liquid's product description.

"Since the outbreak of Wuhan coronavirus, the demand for our Cordyceps Mycelia Oral Liquid and other nutritional products has increased dramatically. As a public company and being aware of these demands, we feel it is our responsibility to contribute and respond to people's needs in a time when everyone is doing everything in their power to reduce the impact of this disease. We have requested that our employees continue manufacturing even amidst the Chinese New Year's celebrations. We anticipate the demand will continue to increase over the next several months before the coronavirus is fully under control. We are prepared to increase the production capacity at any moment, if necessary," said Mr. Xuezhu Wang, CEO of the Company.

https://www.prnewswire.com/news-releases/sales-of-cordyceps-mycelia-products-surged-over-100-in-january-300994160.html

-----

https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html

-----
ANPING, China, Feb. 25, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has officially entered into disinfectants industry. The first batch of 2 million bottles of 75% Alcohol Disinfectant were sold out on launch day. The shipment has begun this week.

The Company has obtained the Sanitation License of Disinfection Product Manufacturer ("Sanitation License") issued by Fujian Provincial Heath Commission, which gives the Company permissions to produce all types of disinfectants, including 75% Alcohol Disinfectant, 84 Disinfectant, and Hand Free Disinfectant, etc. Sanitation License imposes very high standards for the applicants, including the review of the production process, the quality assurance system, the test reports of the production environment and production water, etc. The application process usually takes at least a few months. Due to the outbreak of the Novel Coronavirus, the government has accelerated the application process and gave the Company the approval within 2 weeks.


"We are honored to shoulder the responsibilities to alleviate the supply shortage of epidemic prevention supplies such as disinfectants. Although we are a GMP certified company, we have upgraded and transformed our workshop and production procedures during the application process to meet all the requirements to be a qualified disinfectants manufacturer. We will do our best to produce as much as possible disinfectants products and nutritional products during the epidemic period, and contribute to the prevention and control of the Novel Coronavirus." said Mr. Xuezhu Wang, CEO of the Company.

https://www.prnewswire.com/news-releases/happiness-biotech-officially-entered-into-disinfectants-industry-301010439.html

----
https://www.sec.gov/Archives/edgar/data/1751876/000121390020003810/sc13g0220bian_happiness.htm
https://www.sec.gov/Archives/edgar/data/1751876/000121390020003809/sc13d0220wang_happiness.htm

https://finviz.com/quote.ashx?t=HAPP



------------------- "Opportunities multiply as they are seized" -- Sun Tzu circa 500 B.C. -------------------

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser SunTzu772: Reward | Watch | IgnoreHAPP: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add HAPP
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.